Showing results (721-730 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|April 20, 2011
The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancerS M Chan, F J Garcia, J L Chin, et al.
Prostate Cancer and Prostatic Diseases|April 20, 2011
Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasisT Sasaki, T Onishi, A Hoshina
Prostate Cancer and Prostatic Diseases|June 22, 2011
Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysisS P Elliott, T J Wilt, K M Kuntz
Prostate Cancer and Prostatic Diseases|July 6, 2011
Predictive value of digital rectal examination for prostate cancer detection is modified by obesityD I Chu, C De Nunzio, L Gerber, et al.
Prostate Cancer and Prostatic Diseases|November 7, 2007
Variants in circadian genes and prostate cancer risk: a population-based study in ChinaL W Chu, Y Zhu, K Yu, et al.
Prostate Cancer and Prostatic Diseases|August 22, 2007
Influence of the docetaxel administration period (neoadjuvant or concomitant) in relation to HIFU treatment on the growth of Dunning tumors: results of a preliminary studyP Paparel, J Y Chapelon, A Bissery, et al.
Prostate Cancer and Prostatic Diseases|May 9, 2012
Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal modelH-W Chen, Y-F Chang, H-Y Chuang, et al.
Prostate Cancer and Prostatic Diseases|February 16, 2012
Role of 5α-reductase inhibitors in benign prostatic diseasesF Azzouni, J Mohler
Prostate Cancer and Prostatic Diseases|February 1, 2012
Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopyR Dittrich, J Kurth, E A Decelle, et al.
Prostate Cancer and Prostatic Diseases|September 7, 2011
Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysisA Serpa Neto, M Tobias-Machado, M A P Esteves, et al.
Pageof 199